Notes | 2024 $ ’000 | 2023 $ ’000 | |
Assets | |||
Investments | |||
| Financial investments | 11 | ||
| Deposits with ceding undertakings | | ||
| Reinsurers' share of technical provisions | |||
| Provision for unearned premiums | 5 | ||
| Claims outstanding | 5 | ||
| Debtors | |||
| Debtors arising out of direct insurance operations | 12 | ||
| Debtors arising out of reinsurance operations | 13 | ||
| Other debtors | 14 | ||
| Other assets | |||
| Cash at bank and in hand | |||
| Other | | ||
| Prepayments and accrued income | |||
| Deferred acquisition costs | 5 | ||
| Other prepayments and accrued income | | ||
| Total assets |
Notes | 2024 $ ’000 | 2023 $ ’000 | |
Members’ balance and liabilities | |||
Capital and reserves | |||
Members’ balances | |||
| Technical provisions | |||
| Provision for unearned premiums | 5 | ||
| Claims outstanding | 5 | ||
| Creditors | |||
| Creditors arising out of direct insurance operations | 15 | ||
| Creditors arising out of reinsurance operations | 16 | ||
| Amounts owed to credit institutions | | ||
| Other creditors including taxation and social security | 17 | | |
Accruals and deferred income | |||
Total liabilities | |||
| Total liabilities, capital and reserves |
2024 $’000 | 2023 $’000 | |
Members’ balances brought forward at 1 January | ||
Total comprehensive income for the year | ||
Payments of profit to members’ personal reserve funds | ||
Losses collected on closure of underwriting year | ||
Cash calls on open underwriting years | ||
Members agent fees | ||
Net movement on funds in syndicate | ||
Other | ||
| Members’ balances carried forward at 31 December |
Notes | 2024 $ ’000 | 2023 $ ’000 | |
| Cash flows from operating activities | |||
| Profit for the financial year | |||
| Adjustments: | |||
| Increase in gross technical provisions | |||
(Increase) in reinsurers’ share of gross technical provisions | ( | ( | |
| (Increase) in debtors | ( | ( | |
| Increase in creditors | |||
| (Increase) in deposits received from reinsurers | |||
| Movement in other assets/liabilities | ( | ( | |
| Foreign exchange | |||
| Investment return | ( | ( | |
| Net cash flows from operating activities | |||
| Cash flows from investing activities | |||
| Purchase of equity and debt instruments | | ||
| Sale of equity and debt instruments | | ||
| Investment income received | |||
| Net cash flows from investing activities | | ||
| Cash flows from financing activities | |||
| Distribution of profit | | ||
| Collection of losses | | ||
| Injection/(release) of Funds in Syndicate | | ||
| Other | | ||
| Net cash flows from financing activities | | ||
| Net increase in cash and cash equivalents | |||
Cash and cash equivalents at the beginning of the year | |||
| Foreign exchange on cash and cash equivalents | ( | ||
| Cash and cash equivalents at the end of the year | 18 |